CHRONIC ACTINOMYCES NEUII ENDOPHTHALMITIS POSTCATARACT SURGERY TREATED WITH INTRAVENOUS AND INTRAMUSCULAR ANTIBIOTICS

Carol Tadrous1, Nadine Cheffi2,3, Rishi B Gupta2

  • 1Department of Ophthalmology, University of British Columbia, Vancouver, BC, Canada.

Abstract

Insights

Recalcitrant Actinomyces neuii chronic postoperative endophthalmitis (CPE) requires prolonged systemic penicillin and intraocular lens (IOL) explantation. Pharmacokinetic confirmation of intravitreal drug levels supports this successful treatment approach for sustained resolution.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Microbiology

Background:

  • Chronic postoperative endophthalmitis (CPE) can be challenging to treat.
  • Actinomyces neuii is an unusual pathogen causing CPE.
  • Recalcitrant cases necessitate exploring alternative therapeutic strategies.

Purpose of the Study:

  • To report a successful treatment of recalcitrant Actinomyces neuii CPE.
  • To demonstrate the efficacy of prolonged systemic penicillin therapy.
  • To confirm therapeutic intravitreal drug levels via pharmacokinetic analysis.

Main Methods:

  • Retrospective case report.
  • Focused literature review.
  • Intravenous and intramuscular penicillin G administration.
  • Intraocular lens (IOL) explantation.
  • Pharmacokinetic analysis of intravitreal penicillin G levels.

Main Results:

  • A 77-year-old male with recurrent CPE due to A. neuii showed sustained resolution.
  • Treatment involved prolonged systemic penicillin G and IOL explantation.
  • Achieved therapeutic intravitreal penicillin G concentrations (3.5 μg/mL).
  • Visual acuity was limited by prior macular edema complications.

Conclusions:

  • Systemic therapy and interdisciplinary management are crucial for recalcitrant CPE.
  • Prolonged antibiotic courses with confirmed intraocular concentrations and IOL removal are effective.
  • This approach offers sustained resolution for complex endophthalmitis cases.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...